| Literature DB >> 9619719 |
F Puzzilli1, A Ruggeri, L Mastronardi, D Di Stefano, P Lunardi.
Abstract
Glioblastoma multiforme is the most malignant tumor of the glial series. The average survival of patients with this tumor ranges from 6 to 12 months. The case of a patient who survived for more than 11 years after diagnosis of a temporal-occipital glioblastoma which was treated with surgery, radiotherapy and chemotherapy is described. The authors deduce that among patients with glioblastoma multiforme (GM), those with a long disease-free interval after initial diagnosis who undergo multimodal therapy, including aggressive tumor removal, are the most likely long-term survivors (LS). Other factors which appeared to be related to longer survival were younger age and high Karnofsky scores.Entities:
Mesh:
Year: 1998 PMID: 9619719 DOI: 10.1177/030089169808400115
Source DB: PubMed Journal: Tumori ISSN: 0300-8916